JENNIFER CARMICHAEL: Open Payments
NPI 1669808341 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,787 in 42 payments from 11 companies in 2025. Trend: 2023 $1,374 · 2024 $1,484 · 2025 $1,787
Food & beverage: $1,688Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $568 |
| Janssen Biotech, Inc. | 4 | $292 |
| Phathom Pharmaceuticals, Inc. | 7 | $231 |
| GENZYME CORPORATION | 3 | $184 |
| Aimmune Therapeutics, Inc. | 1 | $123 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $110 |
| PFIZER INC. | 5 | $98 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
Products named: TREMFYA, VOQUEZNA, DUPIXENT, RINVOQ, SKYRIZI, CREON, ZENPEP, XIFAXAN.
Industry payments across WA — which companies pay providers there.
